Ask the Expert

Hodgkin Lymphoma: Your Questions Answered

How is the treatment landscape changing for Hodgkin lymphoma? Tune in for news on novel immunotherapies, minimizing toxicities and side effect management strategies from Dr. John Sweetenham.

John Sweetenham, MD, FRCPC, FACP, Andrew Schorr

Navigating Lymphoma Care During COVID-19

Leading expert Dr. Joshua Brody describes the nuances of managing lymphoma during the coronavirus outbreak. Watch as he discusses treatment, risks and disease-specific precautions.

Joshua Brody, MD, Esther Schorr

Latest News

How Are Young Adults with Hodgkin Lymphoma Impacted by Treatment?

Joshua Brody, MD, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Patient Demographics for Hodgkin Lymphoma: Understanding Disease Development in Different Age Groups

Joshua Brody, MD, Esther Schorr, Andrew Evens, DO, MSc, FACP, Andrew Schorr

Is There a Higher Chance of Relapse for Primary Refractory Hodgkin Lymphoma Patients?

Beth Kart Probert, John Burke, MD

Ask the Expert: Hodgkin Lymphoma

Beth Kart Probert, John Burke, MD